Worth reading
61In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
497000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the First Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses)
発行・処分する株式数
Shares delivered since the beginning of the month: 497,000 shares (497,000 new shares; 0 transferred treasury shares)
Intended allottee
EVO FUND (allottee of the First Series Stock Acquisition Rights)
Terms of the stock acquisition rights
Exercise price
1 June: ¥211; 2 June: ¥210; 3 June: ¥210. Details and floor of the exercise price adjustment clause: Not disclosed
Number of Stock Acquisition Rights
Total issued: 9,860 rights; exercised since the beginning of the month: 4,970 rights; unexercised as of the end of the previous month: 5,500 rights; currently unexercised: 530 rights
Most recent equity financing
Timing 24 February 2026 / Type Issuance of new shares and Series 1 stock acquisition rights with exercise price adjustment clauses through a third-party allotment / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the First Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses) |
| Number of shares to be issued or disposed of | Shares delivered since the beginning of the month: 497,000 shares (497,000 new shares; 0 transferred treasury shares) |
| Intended allottee | EVO FUND (allottee of the First Series Stock Acquisition Rights) |
| Total number of issued shares | 7,889,350 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | 1 June: ¥211; 2 June: ¥210; 3 June: ¥210. Details and floor of the exercise price adjustment clause: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 9,860 rights; exercised since the beginning of the month: 4,970 rights; unexercised as of the end of the previous month: 5,500 rights; currently unexercised: 530 rights |
| Most recent equity financing | Timing 24 February 2026 / Type Issuance of new shares and Series 1 stock acquisition rights with exercise price adjustment clauses through a third-party allotment / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the large-scale exercise of these Stock Acquisition Rights during the period from 1 June 2026 to 3 June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.